Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 22, 2026

Trump sues ‘woke’ JP Morgan for $5bn over debanking

View original at uk.finance.yahoo.com
Trump sues ‘woke’ JP Morgan for $5bn over debanking Donald Trump is suing JP Morgan and its chief executive, Jamie Dimon. - Krisztian Bocsi/Bloomberg Donald Trump is suing JP Morgan and its chief executive Jamie Dimon for $5bn (£3.7bn) over claims it debanked him…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trumpquake not just seismic, but permanent

    80% confidence
  • No plan to pay to acquire Greenland

    80% confidence
  • US asset sell-off unlikely because US is prettiest house on ugly street

    80% confidence
  • JP Morgan doesn't close accounts for political or religious reasons but only when they create legal or regulatory risk

    80% confidence
  • Now hard yards of finding way forward on security in Arctic after tariff threat lifted

    80% confidence
  • People will want humanoid robots for looking after pets/children, caring for parents in old age

    80% confidence
  • Future will have billions of humanoid robots

    80% confidence
  • JP Morgan incorrectly and inappropriately debanked Trump and his businesses after January 6th protest for political reasons

    80% confidence
  • If anyone would know if there were aliens among us it would be me given satellite array

    80% confidence
  • Lesson from Taco Wednesday is not that risk is gone, markets still trading Trump in real time

    80% confidence
  • Expects Bank of England rates to move in downward direction

    80% confidence
  • Denmark pension fund move to exit treasuries is irrelevant

    80% confidence
  • Lowest cost place to put AI will be space, true within 2 years maybe 3 at latest

    80% confidence
  • Limiting factor for AI deployment is fundamentally electrical power

    80% confidence
  • SpaceX refuellable rockets will bring space travel cost below $100 per pound

    80% confidence
  • US would not use military force on Greenland

    80% confidence
  • Trump lawsuit has no merit

    80% confidence
  • JP Morgan needed to distance itself from President Trump and his conservative political views

    80% confidence
  • US insurers halving premiums for customers with Tesla software

    80% confidence
  • AI growth limited by ability to create energy to power it

    80% confidence
  • Tesla hopes for supervised full self-driving approval in Europe hopefully next month, similar timing for China

    80% confidence
  • Virtually no inflation and extraordinarily high economic growth in US

    80% confidence
  • Trump pulled a predictable U-turn

    80% confidence
  • Trump's policies are a rupture, old order is dead, heading to world without rules

    80% confidence
  • Trump's attacks on Fed Chairman Jerome Powell threaten inflation

    80% confidence
  • Thanked UK PM Keir Starmer for very strong support during quite a difficult time

    80% confidence
  • Trump's America first policies are a rupture, urged middle-sized countries to group together

    80% confidence
  • Need to assume life and consciousness extremely rare and might only be us

    80% confidence
  • My plan is to open up to EU, US, China. The US does trade with China

    80% confidence
  • AI chip production increasing exponentially but electricity increasing only 3-4% per year

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com